Semaglutide Dosage Chart: How Dosing Works

The Two FDA-Approved Semaglutide Products and Why Their Doses Differ

Semaglutide is the active ingredient in three distinct products, and the dosing chart that applies to you depends entirely on which one you are prescribed. Ozempic is an injectable form approved for managing blood sugar in adults with type 2 diabetes. Wegovy is also an injectable form of semaglutide but is approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Rybelsus is an oral tablet version indicated for type 2 diabetes.

Although Ozempic and Wegovy use the same molecule, their approved dose ceilings and titration pathways differ because the clinical trials supporting each product used different target doses. Wegovy's maintenance dose of 2.4 mg is higher than Ozempic's ceiling of 2 mg, reflecting the dosing found effective for sustained weight loss. Rybelsus has its own separate dosing ladder entirely because oral bioavailability of semaglutide is significantly lower than injectable delivery, requiring higher milligram amounts to achieve comparable effects. Understanding which product and indication applies to you is the essential first step before interpreting any dosage chart.

How Semaglutide Titration Works

The core logic behind semaglutide titration is straightforward. Starting at a low dose and escalating gradually over several weeks allows the body to adjust to the medication, significantly reducing the risk of nausea, vomiting, and other gastrointestinal side effects that are common at higher doses.

For Ozempic, the standard titration begins at 0.25 mg once weekly for the first four weeks. This starter dose is not considered therapeutically active for blood sugar control. It simply primes the body. After four weeks, the dose steps up to 0.5 mg, which is the first therapeutic dose. Depending on response and tolerability, providers may then increase to 1 mg and, if needed, up to a 2 mg maintenance ceiling.

For Wegovy, the titration takes longer and reaches a higher target. The schedule begins identically at 0.25 mg weekly for four weeks, then steps up to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg as the target maintenance dose. The full journey to maintenance typically takes 16 to 20 weeks.

For Rybelsus, the oral titration is distinct. Patients start at 3 mg daily for 30 days, then increase to 7 mg daily, with a possible final step to 14 mg daily as the maintenance dose.

Semaglutide Dosage Chart by Product

The table below summarizes the key dosing parameters across all three semaglutide products. Keep in mind that individual prescribers may adjust the pace of titration based on tolerability and clinical response.

It is worth noting that maintenance doses shown above are ceilings, not requirements. Some patients achieve their clinical goals at lower doses and may stay at an intermediate step under prescriber guidance. The chart reflects standard schedules, and your own path may look different.

What to Do If You Miss a Dose or Need to Pause

Missing an injection does not automatically mean starting over, but the correct response depends on how much time has passed. For injectable semaglutide, if fewer than five days have passed since the missed dose, you can take it as soon as you remember and then return to your regular weekly schedule. If more than five days have passed, the recommendation is to skip the missed dose entirely and resume on your next scheduled injection day.

A more significant concern arises when a patient needs to pause treatment for two weeks or longer. A prolonged break can reduce the body's adjustment to the medication, meaning resuming at the current dose may feel like starting fresh in terms of side effects. In many cases, prescribers recommend stepping back down to a lower dose and re-titrating upward. Patients should always consult their prescriber before resuming after any substantial gap rather than making this adjustment on their own.

Factors That May Lead a Prescriber to Modify Your Schedule

The standard titration schedule is a starting framework, not a one-size-fits-all prescription. Several factors may lead a prescriber to slow down, pause, or reduce a patient's dose.

Patients with significant gastrointestinal sensitivity, a history of gastroparesis, or kidney concerns may need a more gradual escalation than the standard four-week intervals allow. If nausea, vomiting, or dehydration become difficult to manage at a given dose, a prescriber may hold the escalation, reduce back to the prior dose, or temporarily pause treatment until symptoms resolve.

Age, other medications, and overall health status can all influence how a person tolerates each dose step. The goal is to find the lowest effective dose that helps a patient reach their clinical target, whether that is improved blood sugar control or meaningful weight reduction. Reaching the maximum approved dose is not the goal in itself.

Compounded Semaglutide and the Dosing Risks It Introduces

During periods of high demand and shortage, some patients have turned to compounded semaglutide from compounding pharmacies. It is important to understand that compounded versions of semaglutide are not FDA-approved products and do not come with the standardized dosing charts or verified concentration labeling that brand-name products carry.

Variations in concentration from one compounded batch to another create genuine risks of both overdose and underdose. A patient who believes they are injecting an equivalent amount may actually be receiving a significantly different quantity depending on the preparation. Patients using compounded semaglutide need especially clear communication from their prescriber, including explicit instructions on units versus milligrams and verification of the concentration on each vial. This is one area where close clinical oversight is not optional. Doctronic's 24/7 AI consultations, backed by 99.2% treatment plan alignment with board-certified physicians, can help patients prepare the right questions before speaking with their provider about compounded products.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

For Wegovy, the standard starting dose is 0.25 mg injected once weekly for the first four weeks. This initial dose is considered a starter dose, not a therapeutic one. Its purpose is to help your body adjust gradually and reduce the likelihood of nausea or other gastrointestinal side effects as you begin treatment.

How long does it take to reach the full semaglutide dose?

For Wegovy, reaching the 2.4 mg maintenance dose typically takes approximately 16 to 20 weeks across five dose escalation steps. For Ozempic, the path to the 1 mg or 2 mg maintenance dose takes roughly 8 to 12 weeks. Individual timelines may vary depending on how well each dose is tolerated.

Can I speed up my semaglutide titration schedule?

Speeding up titration is generally not recommended and should never be done without talking to your prescriber first. The gradual escalation schedule is designed specifically to reduce GI side effects like nausea and vomiting. Moving too quickly may increase discomfort and could lead to dehydration or other complications that require pausing treatment entirely.

What should I do if I miss a semaglutide injection?

If fewer than five days have passed since your missed dose, you can take it as soon as you remember and then resume your regular weekly schedule. If more than five days have passed, skip the missed dose and continue with your next scheduled injection. After a gap of more than two weeks, contact your prescriber before resuming, as restarting at a lower dose may be recommended.

Is the semaglutide dosage chart the same for diabetes and weight loss?

No. While Ozempic and Wegovy both contain semaglutide, their dosing charts differ. Ozempic's maintenance ceiling is 2 mg, while Wegovy's target maintenance dose is 2.4 mg. The titration steps and pace also differ between the two. Oral semaglutide (Rybelsus) has its own separate dosing ladder due to lower oral bioavailability.

The Bottom Line

Semaglutide dosing is a structured, gradual process designed to balance effectiveness with tolerability. The right dosage chart depends on which product you are taking and what condition it is prescribed for. Ozempic, Wegovy, and Rybelsus each follow distinct titration paths, and your prescriber may further personalize the pace based on your response. When questions arise between appointments, Doctronic offers free AI consultations available 24/7, with 99.2% treatment plan alignment with board-certified physicians, plus affordable $39 video visits to help you understand your specific dosing plan. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.